BioCentury
ARTICLE | Financial News

Therasis secures $12 million

December 9, 2009 2:40 AM UTC

Cancer company Therasis Inc. (New York, N.Y.) secured $12 million in a series A round from Tilocor Life Science. Therasis plans to develop a cancer pipeline using its Therasis Filter drug discovery te...